Satellos Bioscience Inc (MSLE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,873 | -20,634 | -11,771 | -8,709 | -12,372 |
| Depreciation Amortization | 4 | 2,920 | 5 | 2,479 | 132 |
| Accounts receivable | N/A | N/A | N/A | 1 | 32 |
| Other Working Capital | -1,478 | -753 | 273 | 763 | -388 |
| Other Operating Activity | 2,751 | 215 | 750 | 1,072 | 8,579 |
| Operating Cash Flow | $-23,596 | $-18,252 | $-10,742 | $-4,395 | $-4,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,411 | 4,660 | -12,979 | N/A | N/A |
| PPE Investments | -6 | -4 | -13 | -3 | 1,387 |
| Investing Cash Flow | $-9,417 | $4,656 | $-12,992 | $-3 | $1,387 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 1,662 | N/A | 149 |
| Debt Repayment | N/A | N/A | -1,873 | N/A | N/A |
| Common Stock Issued | 2,241 | 600 | 24,056 | 2,117 | 465 |
| Other Financing Activity | 0 | 36,974 | 13,960 | 18 | 5,331 |
| Financing Cash Flow | $2,241 | $37,574 | $37,805 | $2,135 | $5,945 |
| Exchange Rate Effect | 503 | -586 | 851 | -5 | -1 |
| Beginning Cash Position | 40,073 | 16,681 | 1,425 | 3,747 | 573 |
| End Cash Position | 9,804 | 40,073 | 16,347 | 1,480 | 3,887 |
| Net Cash Flow | $-30,269 | $23,392 | $14,922 | $-2,267 | $3,314 |
| Free Cash Flow | |||||
| Operating Cash Flow | -23,596 | -18,252 | -10,742 | -4,395 | -4,016 |
| Capital Expenditure | -6 | -4 | -13 | -3 | -6 |
| Free Cash Flow | -23,602 | -18,256 | -10,756 | -4,397 | -4,022 |